HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiro Iwamoto Selected Research

Osteochondroma (Osteocartilaginous Exostosis)

12/2021Osteochondroma Pathogenesis: Mouse Models and Mechanistic Insights into Interactions with Retinoid Signaling.
4/2020Understanding the Action of RARγ Agonists on Human Osteochondroma Explants.
1/2020Selective Agonists of Nuclear Retinoic Acid Receptor Gamma Inhibit Growth of HCS-2/8 Chondrosarcoma Cells.
3/2013Loss of β-catenin induces multifocal periosteal chondroma-like masses in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiro Iwamoto Research Topics

Disease

24Rheumatoid Arthritis
01/2022 - 06/2004
8Heterotopic Ossification (Ectopic Ossification)
01/2020 - 02/2010
7Type 2 Diabetes Mellitus (MODY)
11/2022 - 01/2018
7Neoplasms (Cancer)
12/2021 - 12/2010
5Adult-Onset Still's Disease
08/2022 - 11/2008
5Wounds and Injuries (Trauma)
08/2021 - 01/2016
4Body Weight (Weight, Body)
11/2022 - 08/2009
4Osteochondroma (Osteocartilaginous Exostosis)
12/2021 - 03/2013
4Inflammation (Inflammations)
01/2018 - 01/2010
4Infections
05/2017 - 01/2005
4Hypertrophy
11/2010 - 05/2005
3Osteogenesis Imperfecta (Lobstein Disease)
01/2022 - 08/2012
3Stroke (Strokes)
01/2020 - 01/2018
3Liver Diseases (Liver Disease)
01/2019 - 11/2008
2Albuminuria
11/2022 - 01/2020
2Disease Progression
07/2022 - 04/2002
2Pneumonia (Pneumonitis)
01/2022 - 03/2009
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 12/2004
2Thrombotic Microangiopathies
10/2021 - 01/2013
2Disseminated Intravascular Coagulation
07/2021 - 04/2009
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2020 - 04/2002
2Thromboangiitis Obliterans (Buerger's Disease)
02/2020 - 07/2006
2Foot Ulcer
03/2019 - 01/2012
2Tuberculosis (Tuberculoses)
05/2017 - 01/2005
2Osteoarthritis
02/2016 - 03/2008
2Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
01/2016 - 04/2011
2Systemic Scleroderma (Systemic Sclerosis)
01/2013 - 01/2006
2Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
09/2009 - 03/2009
2Liver Failure
04/2009 - 11/2008
1Chronic Renal Insufficiency
11/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022
1Encephalitis (Encephalitis, Rasmussen)
01/2022
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022
1Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1Bronchiectasis
01/2022
1Deglutition Disorders (Dysphagia)
10/2021
1Thrombocytopenia (Thrombopenia)
10/2021
1Cicatrix (Scar)
08/2021
1Pleurisy (Pleuritis)
07/2021
1Hemorrhage
01/2021

Drug/Important Bio-Agent (IBA)

6PalovaroteneIBA
12/2021 - 01/2016
6Methotrexate (Mexate)FDA LinkGeneric
08/2017 - 12/2004
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017 - 05/2008
5Pharmaceutical PreparationsIBA
08/2022 - 06/2004
5Immunosuppressive Agents (Immunosuppressants)IBA
01/2022 - 04/2002
5Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
12/2021 - 04/2011
5Biomarkers (Surrogate Marker)IBA
12/2020 - 08/2003
5tocilizumab (atlizumab)FDA Link
01/2014 - 04/2009
4RetinoidsIBA
12/2021 - 11/2010
4GlucocorticoidsIBA
08/2020 - 04/2009
4Etanercept (Enbrel)FDA Link
05/2017 - 01/2010
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2015
3CateninsIBA
12/2021 - 03/2013
3Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2021 - 11/2008
3Prednisolone (Predate)FDA LinkGeneric
05/2020 - 08/2009
3AntibodiesIBA
02/2020 - 02/2005
3Tumor Necrosis Factor InhibitorsIBA
05/2017 - 01/2011
3Infliximab (Remicade)FDA Link
05/2017 - 01/2005
3beta CateninIBA
11/2009 - 05/2005
3CollagenIBA
09/2009 - 05/2007
3SteroidsIBA
04/2009 - 07/2006
2AlbuminsIBA
11/2022 - 04/2020
2CreatinineIBA
11/2022 - 04/2020
2Insulin Glargine (Lantus)FDA Link
07/2022 - 01/2018
2Biological ProductsIBA
01/2022 - 05/2016
2Collagen Type I (Type I Collagen)IBA
01/2022 - 01/2019
2Transcription Factors (Transcription Factor)IBA
12/2021 - 01/2017
2MethylprednisoloneFDA LinkGeneric
10/2021 - 11/2008
2HaptoglobinsIBA
10/2021 - 01/2015
2Ferritins (Ferritin)IBA
07/2021 - 09/2018
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2020 - 01/2020
2AutoantibodiesIBA
08/2020 - 02/2005
2Retinoic Acid Receptor gammaIBA
04/2020 - 01/2020
2Phospholipids (Phosphatides)FDA LinkGeneric
02/2020 - 01/2018
2EnzymesIBA
09/2018 - 02/2005
2Certolizumab PegolFDA Link
08/2017 - 01/2016
2Peptides (Polypeptides)IBA
09/2016 - 05/2015
2VaccinesIBA
09/2016 - 11/2012
2Immunoglobulin G (IgG)IBA
09/2016 - 10/2002
2Interleukin-33IBA
05/2012 - 01/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2007 - 05/2005
1Glucagon-Like Peptide-1 ReceptorIBA
11/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
11/2022
1Hemoglobins (Hemoglobin)IBA
11/2022
1dulaglutideIBA
11/2022
1Long-Acting Insulin (Insulin, Long Acting)FDA Link
07/2022
1insulin aspart drug combination insulin degludecIBA
07/2022
1Insulin (Novolin)FDA Link
07/2022
1insulin degludecIBA
07/2022
1InsulinsIBA
07/2022
1Insulin SecretagoguesIBA
07/2022
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
12/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021
1ORALIT (ORS)IBA
01/2021
1sonidegibIBA
01/2021

Therapy/Procedure

15Therapeutics
07/2022 - 11/2008
4Glycemic Control
12/2020 - 01/2018
3Surgical Amputation (Amputations)
03/2019 - 01/2016
1Oral Administration
08/2021